Exact Mass: 475.21005880000007

Exact Mass Matches: 475.21005880000007

Found 60 metabolites which its exact mass value is equals to given mass value 475.21005880000007, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Monatepil

4-[4-(4-fluorophenyl)piperazin-1-yl]-N-{9-thiatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}butanimidic acid

C28H30FN3OS (475.2093502)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

ACMC-20m7v3

ACMC-20m7v3

C27H29N3O5 (475.21071040000004)


   

NSC524581

NSC524581

C27H29N3O5 (475.21071040000004)


   

Phe Tyr Phe

Phe Tyr Phe

C27H29N3O5 (475.21071040000004)


   

Cys Glu Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carboxybutanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O7S (475.21005880000007)


   

Cys Glu Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C19H33N5O7S (475.21005880000007)


   

Cys Lys Glu Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O7S (475.21005880000007)


   

Cys Lys Pro Glu

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C19H33N5O7S (475.21005880000007)


   

Cys Pro Glu Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-carboxybutanamido]hexanoic acid

C19H33N5O7S (475.21005880000007)


   

Cys Pro Lys Glu

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}hexanamido]pentanedioic acid

C19H33N5O7S (475.21005880000007)


   

Glu Cys Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-sulfanylpropanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O7S (475.21005880000007)


   

Glu Cys Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C19H33N5O7S (475.21005880000007)


   

Glu Lys Cys Pro

(2S)-1-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carboxybutanamido]hexanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O7S (475.21005880000007)


   

Glu Lys Pro Cys

(4S)-4-amino-4-{[(2S)-6-amino-1-[(2S)-2-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pyrrolidin-1-yl]-1-oxohexan-2-yl]carbamoyl}butanoic acid

C19H33N5O7S (475.21005880000007)


   

Glu Pro Cys Lys

(2S)-6-amino-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]hexanoic acid

C19H33N5O7S (475.21005880000007)


   

Glu Pro Lys Cys

(4S)-4-amino-5-[(2S)-2-{[(1S)-5-amino-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pentyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H33N5O7S (475.21005880000007)


   

Lys Cys Glu Pro

(2S)-1-[(2S)-4-carboxy-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]butanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O7S (475.21005880000007)


   

Lys Cys Pro Glu

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C19H33N5O7S (475.21005880000007)


   

Lys Glu Cys Pro

(2S)-1-[(2R)-2-[(2S)-4-carboxy-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O7S (475.21005880000007)


   

Lys Glu Pro Cys

(4S)-5-[(2S)-2-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pyrrolidin-1-yl]-4-[(2S)-2,6-diaminohexanamido]-5-oxopentanoic acid

C19H33N5O7S (475.21005880000007)


   

Lys Pro Cys Glu

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]pentanedioic acid

C19H33N5O7S (475.21005880000007)


   

Lys Pro Glu Cys

(4S)-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-4-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}butanoic acid

C19H33N5O7S (475.21005880000007)


   

Phe Phe Tyr

Phe Phe Tyr

C27H29N3O5 (475.21071040000004)


   

Met Pro Gln Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C19H33N5O7S (475.21005880000007)


   

Met Pro Thr Gln

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C19H33N5O7S (475.21005880000007)


   

Met Gln Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C19H33N5O7S (475.21005880000007)


   

Met Gln Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O7S (475.21005880000007)


   

Met Thr Pro Gln

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C19H33N5O7S (475.21005880000007)


   

Met Thr Gln Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxybutanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O7S (475.21005880000007)


   

Pro Cys Glu Lys

(2S)-6-amino-2-[(2S)-4-carboxy-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]butanamido]hexanoic acid

C19H33N5O7S (475.21005880000007)


   

Pro Cys Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]hexanamido]pentanedioic acid

C19H33N5O7S (475.21005880000007)


   

Pro Glu Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-4-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-sulfanylpropanamido]hexanoic acid

C19H33N5O7S (475.21005880000007)


   

Pro Glu Lys Cys

(4S)-4-{[(1S)-5-amino-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pentyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C19H33N5O7S (475.21005880000007)


   

Pro Lys Cys Glu

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-sulfanylpropanamido]pentanedioic acid

C19H33N5O7S (475.21005880000007)


   

Pro Lys Glu Cys

(4S)-4-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C19H33N5O7S (475.21005880000007)


   

Pro Met Gln Thr

(2S,3R)-2-[(2S)-4-carbamoyl-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]-3-hydroxybutanoic acid

C19H33N5O7S (475.21005880000007)


   

Pro Met Thr Gln

(2S)-4-carbamoyl-2-[(2S,3R)-3-hydroxy-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]butanoic acid

C19H33N5O7S (475.21005880000007)


   

Pro Gln Met Thr

(2S,3R)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanoic acid

C19H33N5O7S (475.21005880000007)


   

Pro Gln Thr Met

(2S)-2-[(2S,3R)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanoic acid

C19H33N5O7S (475.21005880000007)


   

Pro Thr Met Gln

(2S)-4-carbamoyl-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-(methylsulfanyl)butanamido]butanoic acid

C19H33N5O7S (475.21005880000007)


   

Pro Thr Gln Met

(2S)-2-[(2S)-4-carbamoyl-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]-4-(methylsulfanyl)butanoic acid

C19H33N5O7S (475.21005880000007)


   

Gln Met Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C19H33N5O7S (475.21005880000007)


   

Gln Met Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O7S (475.21005880000007)


   

Gln Pro Met Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-3-hydroxybutanoic acid

C19H33N5O7S (475.21005880000007)


   

Gln Pro Thr Met

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-4-(methylsulfanyl)butanoic acid

C19H33N5O7S (475.21005880000007)


   

Gln Thr Met Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O7S (475.21005880000007)


   

Gln Thr Pro Met

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C19H33N5O7S (475.21005880000007)


   

Tyr Phe Phe

Tyr Phe Phe

C27H29N3O5 (475.21071040000004)


   

Thr Met Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C19H33N5O7S (475.21005880000007)


   

Thr Met Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O7S (475.21005880000007)


   

Thr Pro Met Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C19H33N5O7S (475.21005880000007)


   

Thr Pro Gln Met

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C19H33N5O7S (475.21005880000007)


   

Thr Gln Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C19H33N5O7S (475.21005880000007)


   

Thr Gln Pro Met

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C19H33N5O7S (475.21005880000007)


   

[1-(3-Hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic acid pyridin-4-ylmethyl ester

[1-(3-Hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic acid pyridin-4-ylmethyl ester

C27H29N3O5 (475.21071040000004)


   

(5S,5aR,8aS,8bR)-7-tert-butyl-5-(4-methoxyphenyl)-8b-methyl-2-(3-methylphenyl)-5a,8a-dihydro-5H-pyrrolo[1,2]pyrrolo[4,5-a]imidazole-1,3,6,8-tetrone

(5S,5aR,8aS,8bR)-7-tert-butyl-5-(4-methoxyphenyl)-8b-methyl-2-(3-methylphenyl)-5a,8a-dihydro-5H-pyrrolo[1,2]pyrrolo[4,5-a]imidazole-1,3,6,8-tetrone

C27H29N3O5 (475.21071040000004)


   

Phe-Phe-Tyr

Phe-Phe-Tyr

C27H29N3O5 (475.21071040000004)


   

Tyr-Phe-Phe

Tyr-Phe-Phe

C27H29N3O5 (475.21071040000004)


   

Phe-Tyr-Phe

Phe-Tyr-Phe

C27H29N3O5 (475.21071040000004)


   

Monatepil

N-(6,11-DIHYDRODIBENZO[B,E]THIEPIN-11-YL)-4-(4-(4-FLUOROPHENYL)PIPERAZIN-1-YL)BUTANAMIDE

C28H30FN3OS (475.2093502)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker